Industry: Medical Devices & Consumables
Published Date: 2025-01-13
Pages: 166 Pages
Report ld: 3501273
Request Sample
Customized Report
Antimicrobial Efficacy Testing Market Size(US$)

CAGR 2025-2031
3.9%
Market Size,2031
USD 425
Million
Market Snapshot
Source: Secondary research, interviews with experts, and QYResearch analysis
The global market for Antimicrobial Efficacy Testing was estimated to be worth US$ 326 million in 2024 and is forecast to a readjusted size of US$ 425 million by 2031 with a CAGR of 3.9% during the forecast period 2025-2031.
Efficacy Testing is a set of procedures in product research and development that are conducted to test the product’s intended purpose in order to substantiate those all-important claims that appear on your packaging or in your advertisements.
The Antimicrobial Efficacy Testing market was experiencing growth due to increasing concerns about antimicrobial resistance, infection control, and the need to ensure the effectiveness of antimicrobial products and treatments. Antimicrobial efficacy testing involves assessing the ability of antimicrobial agents to inhibit or kill microorganisms such as bacteria, viruses, and fungi.
This report aims to provide a comprehensive presentation of the global market for Antimicrobial Efficacy Testing, focusing on the total sales volume, sales revenue, price, key companies market share and ranking, together with an analysis of Antimicrobial Efficacy Testing by region & country, by Type, and by Application.
The Antimicrobial Efficacy Testing market size, estimations, and forecasts are provided in terms of sales volume (K Units) and sales revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. With both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Antimicrobial Efficacy Testing.
MARKET SEGMENTATION
CHAPTER OUTLINE
Chapter 1: Introduces the report scope of the report, global total market size (value, volume and price). This chapter also provides the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 2: Detailed analysis of Antimicrobial Efficacy Testing manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 4: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 5: Sales, revenue of Antimicrobial Efficacy Testing in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 6: Sales, revenue of Antimicrobial Efficacy Testing in country level. It provides sigmate data by Type, and by Application for each country/region.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 8: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 9: Conclusion.
QYRESEARCH'S STRENGTHS
Unlike generic global market reports, this study combines macro-level industry trends with hyper-local operational intelligence, empowering data-driven decisions across the Compound Chocolate value chain, addressing:
We identify regional market threats and growth prospects to guide your overseas layout.
We adjust product portfolios in line with local consumption habits.
We unpack rivals’ operation strategies for scattered and highly concentrated industries.
We cover competition landscape, full supply chain and quantified market size data, and deliver tailor-made customized surveys to meet your unique business demands.
We own self-owned massive exclusive databases, backed by 19 years of global market research experience across thousands of sectors.
Our team operates 24 hours a day, 365 days a year, enabling ultra-fast report turnaround to respond to your research needs efficiently.
We integrate regional risk assessment, localized product optimization and competitor analysis to deliver actionable market strategies.
All data is cross-verified from multiple industry sources to deliver thorough, precise analysis that supports reliable corporate strategic decisions.
We provide responsive, dedicated after-sales support to resolve all follow-up inquiries about reports, data and industry interpretation.
TABLE OF CONTENTS
1 Market Overview
1.1 Antimicrobial Efficacy Testing Product Introduction
1.2 Global Antimicrobial Efficacy Testing Market Size Forecast
1.2.1 Global Antimicrobial Efficacy Testing Sales Value (2020-2031)
1.2.2 Global Antimicrobial Efficacy Testing Sales Volume (2020-2031)
1.2.3 Global Antimicrobial Efficacy Testing Sales Price (2020-2031)
1.3 Antimicrobial Efficacy Testing Market Trends & Drivers
1.3.1 Antimicrobial Efficacy Testing Industry Trends
1.3.2 Antimicrobial Efficacy Testing Market Drivers & Opportunity
1.3.3 Antimicrobial Efficacy Testing Market Challenges
1.3.4 Antimicrobial Efficacy Testing Market Restraints
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Competitive Analysis by Company
2.1 Global Antimicrobial Efficacy Testing Players Revenue Ranking (2024)
2.2 Global Antimicrobial Efficacy Testing Revenue by Company (2020-2025)
2.3 Global Antimicrobial Efficacy Testing Players Sales Volume Ranking (2024)
2.4 Global Antimicrobial Efficacy Testing Sales Volume by Company Players (2020-2025)
2.5 Global Antimicrobial Efficacy Testing Average Price by Company (2020-2025)
2.6 Key Manufacturers Antimicrobial Efficacy Testing Manufacturing Base and Headquarters
2.7 Key Manufacturers Antimicrobial Efficacy Testing Product Offered
2.8 Key Manufacturers Time to Begin Mass Production of Antimicrobial Efficacy Testing
2.9 Antimicrobial Efficacy Testing Market Competitive Analysis
2.9.1 Antimicrobial Efficacy Testing Market Concentration Rate (2020-2025)
2.9.2 Global 5 and 10 Largest Manufacturers by Antimicrobial Efficacy Testing Revenue in 2024
2.9.3 Global Top Manufacturers by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Antimicrobial Efficacy Testing as of 2024)
2.10 Mergers & Acquisitions, Expansion
3 Segmentation by Type
3.1 Introduction by Type
3.1.1 Preservative Efficacy Testing
3.1.2 Disinfectant Efficacy Testing
3.2 Global Antimicrobial Efficacy Testing Sales Value by Type
3.2.1 Global Antimicrobial Efficacy Testing Sales Value by Type (2020 VS 2024 VS 2031)
3.2.2 Global Antimicrobial Efficacy Testing Sales Value, by Type (2020-2031)
3.2.3 Global Antimicrobial Efficacy Testing Sales Value, by Type (%) (2020-2031)
3.3 Global Antimicrobial Efficacy Testing Sales Volume by Type
3.3.1 Global Antimicrobial Efficacy Testing Sales Volume by Type (2020 VS 2024 VS 2031)
3.3.2 Global Antimicrobial Efficacy Testing Sales Volume, by Type (2020-2031)
3.3.3 Global Antimicrobial Efficacy Testing Sales Volume, by Type (%) (2020-2031)
3.4 Global Antimicrobial Efficacy Testing Average Price by Type (2020-2031)
4 Segmentation by Application
4.1 Introduction by Application
4.1.1 Pharmaceutical Manufacturing
4.1.2 Cosmetics and Personal Care Product
4.1.3 Medical Device
4.1.4 Others
4.2 Global Antimicrobial Efficacy Testing Sales Value by Application
4.2.1 Global Antimicrobial Efficacy Testing Sales Value by Application (2020 VS 2024 VS 2031)
4.2.2 Global Antimicrobial Efficacy Testing Sales Value, by Application (2020-2031)
4.2.3 Global Antimicrobial Efficacy Testing Sales Value, by Application (%) (2020-2031)
4.3 Global Antimicrobial Efficacy Testing Sales Volume by Application
4.3.1 Global Antimicrobial Efficacy Testing Sales Volume by Application (2020 VS 2024 VS 2031)
4.3.2 Global Antimicrobial Efficacy Testing Sales Volume, by Application (2020-2031)
4.3.3 Global Antimicrobial Efficacy Testing Sales Volume, by Application (%) (2020-2031)
4.4 Global Antimicrobial Efficacy Testing Average Price by Application (2020-2031)
5 Segmentation by Region
5.1 Global Antimicrobial Efficacy Testing Sales Value by Region
5.1.1 Global Antimicrobial Efficacy Testing Sales Value by Region: 2020 VS 2024 VS 2031
5.1.2 Global Antimicrobial Efficacy Testing Sales Value by Region (2020-2025)
5.1.3 Global Antimicrobial Efficacy Testing Sales Value by Region (2026-2031)
5.1.4 Global Antimicrobial Efficacy Testing Sales Value by Region (%), (2020-2031)
5.2 Global Antimicrobial Efficacy Testing Sales Volume by Region
5.2.1 Global Antimicrobial Efficacy Testing Sales Volume by Region: 2020 VS 2024 VS 2031
5.2.2 Global Antimicrobial Efficacy Testing Sales Volume by Region (2020-2025)
5.2.3 Global Antimicrobial Efficacy Testing Sales Volume by Region (2026-2031)
5.2.4 Global Antimicrobial Efficacy Testing Sales Volume by Region (%), (2020-2031)
5.3 Global Antimicrobial Efficacy Testing Average Price by Region (2020-2031)
5.4 North America
5.4.1 North America Antimicrobial Efficacy Testing Sales Value, 2020-2031
5.4.2 North America Antimicrobial Efficacy Testing Sales Value by Country (%), 2024 VS 2031
5.5 Europe
5.5.1 Europe Antimicrobial Efficacy Testing Sales Value, 2020-2031
5.5.2 Europe Antimicrobial Efficacy Testing Sales Value by Country (%), 2024 VS 2031
5.6 Asia Pacific
5.6.1 Asia Pacific Antimicrobial Efficacy Testing Sales Value, 2020-2031
5.6.2 Asia Pacific Antimicrobial Efficacy Testing Sales Value by Region (%), 2024 VS 2031
5.7 South America
5.7.1 South America Antimicrobial Efficacy Testing Sales Value, 2020-2031
5.7.2 South America Antimicrobial Efficacy Testing Sales Value by Country (%), 2024 VS 2031
5.8 Middle East & Africa
5.8.1 Middle East & Africa Antimicrobial Efficacy Testing Sales Value, 2020-2031
5.8.2 Middle East & Africa Antimicrobial Efficacy Testing Sales Value by Country (%), 2024 VS 2031
6 Segmentation by Key Countries/Regions
6.1 Key Countries/Regions Antimicrobial Efficacy Testing Sales Value Growth Trends, 2020 VS 2024 VS 2031
6.2 Key Countries/Regions Antimicrobial Efficacy Testing Sales Value
6.2.1 Key Countries/Regions Antimicrobial Efficacy Testing Sales Value, 2020-2031
6.2.2 Key Countries/Regions Antimicrobial Efficacy Testing Sales Volume, 2020-2031
6.3 United States
6.3.1 United States Antimicrobial Efficacy Testing Sales Value, 2020-2031
6.3.2 United States Antimicrobial Efficacy Testing Sales Value by Type (%), 2024 VS 2031
6.3.3 United States Antimicrobial Efficacy Testing Sales Value by Application, 2024 VS 2031
6.4 Europe
6.4.1 Europe Antimicrobial Efficacy Testing Sales Value, 2020-2031
6.4.2 Europe Antimicrobial Efficacy Testing Sales Value by Type (%), 2024 VS 2031
6.4.3 Europe Antimicrobial Efficacy Testing Sales Value by Application, 2024 VS 2031
6.5 China
6.5.1 China Antimicrobial Efficacy Testing Sales Value, 2020-2031
6.5.2 China Antimicrobial Efficacy Testing Sales Value by Type (%), 2024 VS 2031
6.5.3 China Antimicrobial Efficacy Testing Sales Value by Application, 2024 VS 2031
6.6 Japan
6.6.1 Japan Antimicrobial Efficacy Testing Sales Value, 2020-2031
6.6.2 Japan Antimicrobial Efficacy Testing Sales Value by Type (%), 2024 VS 2031
6.6.3 Japan Antimicrobial Efficacy Testing Sales Value by Application, 2024 VS 2031
6.7 South Korea
6.7.1 South Korea Antimicrobial Efficacy Testing Sales Value, 2020-2031
6.7.2 South Korea Antimicrobial Efficacy Testing Sales Value by Type (%), 2024 VS 2031
6.7.3 South Korea Antimicrobial Efficacy Testing Sales Value by Application, 2024 VS 2031
6.8 Southeast Asia
6.8.1 Southeast Asia Antimicrobial Efficacy Testing Sales Value, 2020-2031
6.8.2 Southeast Asia Antimicrobial Efficacy Testing Sales Value by Type (%), 2024 VS 2031
6.8.3 Southeast Asia Antimicrobial Efficacy Testing Sales Value by Application, 2024 VS 2031
6.9 India
6.9.1 India Antimicrobial Efficacy Testing Sales Value, 2020-2031
6.9.2 India Antimicrobial Efficacy Testing Sales Value by Type (%), 2024 VS 2031
6.9.3 India Antimicrobial Efficacy Testing Sales Value by Application, 2024 VS 2031
7 Company Profiles
7.1 Charles River Laboratories
7.1.1 Charles River Laboratories Company Information
7.1.2 Charles River Laboratories Introduction and Business Overview
7.1.3 Charles River Laboratories Antimicrobial Efficacy Testing Sales, Revenue, Price and Gross Margin (2020-2025)
7.1.4 Charles River Laboratories Antimicrobial Efficacy Testing Product Offerings
7.1.5 Charles River Laboratories Recent Development
7.2 WuXi AppTec
7.2.1 WuXi AppTec Company Information
7.2.2 WuXi AppTec Introduction and Business Overview
7.2.3 WuXi AppTec Antimicrobial Efficacy Testing Sales, Revenue, Price and Gross Margin (2020-2025)
7.2.4 WuXi AppTec Antimicrobial Efficacy Testing Product Offerings
7.2.5 WuXi AppTec Recent Development
7.3 Eurofins Scientific
7.3.1 Eurofins Scientific Company Information
7.3.2 Eurofins Scientific Introduction and Business Overview
7.3.3 Eurofins Scientific Antimicrobial Efficacy Testing Sales, Revenue, Price and Gross Margin (2020-2025)
7.3.4 Eurofins Scientific Antimicrobial Efficacy Testing Product Offerings
7.3.5 Eurofins Scientific Recent Development
7.4 SGS
7.4.1 SGS Company Information
7.4.2 SGS Introduction and Business Overview
7.4.3 SGS Antimicrobial Efficacy Testing Sales, Revenue, Price and Gross Margin (2020-2025)
7.4.4 SGS Antimicrobial Efficacy Testing Product Offerings
7.4.5 SGS Recent Development
7.5 Intertek Group
7.5.1 Intertek Group Company Information
7.5.2 Intertek Group Introduction and Business Overview
7.5.3 Intertek Group Antimicrobial Efficacy Testing Sales, Revenue, Price and Gross Margin (2020-2025)
7.5.4 Intertek Group Antimicrobial Efficacy Testing Product Offerings
7.5.5 Intertek Group Recent Development
7.6 Nelson Laboratories
7.6.1 Nelson Laboratories Company Information
7.6.2 Nelson Laboratories Introduction and Business Overview
7.6.3 Nelson Laboratories Antimicrobial Efficacy Testing Sales, Revenue, Price and Gross Margin (2020-2025)
7.6.4 Nelson Laboratories Antimicrobial Efficacy Testing Product Offerings
7.6.5 Nelson Laboratories Recent Development
7.7 Microbac Laboratories
7.7.1 Microbac Laboratories Company Information
7.7.2 Microbac Laboratories Introduction and Business Overview
7.7.3 Microbac Laboratories Antimicrobial Efficacy Testing Sales, Revenue, Price and Gross Margin (2020-2025)
7.7.4 Microbac Laboratories Antimicrobial Efficacy Testing Product Offerings
7.7.5 Microbac Laboratories Recent Development
7.8 Almac Group
7.8.1 Almac Group Company Information
7.8.2 Almac Group Introduction and Business Overview
7.8.3 Almac Group Antimicrobial Efficacy Testing Sales, Revenue, Price and Gross Margin (2020-2025)
7.8.4 Almac Group Antimicrobial Efficacy Testing Product Offerings
7.8.5 Almac Group Recent Development
7.9 North American Science Associates
7.9.1 North American Science Associates Company Information
7.9.2 North American Science Associates Introduction and Business Overview
7.9.3 North American Science Associates Antimicrobial Efficacy Testing Sales, Revenue, Price and Gross Margin (2020-2025)
7.9.4 North American Science Associates Antimicrobial Efficacy Testing Product Offerings
7.9.5 North American Science Associates Recent Development
7.10 Toxikon
7.10.1 Toxikon Company Information
7.10.2 Toxikon Introduction and Business Overview
7.10.3 Toxikon Antimicrobial Efficacy Testing Sales, Revenue, Price and Gross Margin (2020-2025)
7.10.4 Toxikon Antimicrobial Efficacy Testing Product Offerings
7.10.5 Toxikon Recent Development
7.11 Pacific Biolabs
7.11.1 Pacific Biolabs Company Information
7.11.2 Pacific Biolabs Introduction and Business Overview
7.11.3 Pacific Biolabs Antimicrobial Efficacy Testing Sales, Revenue, Price and Gross Margin (2020-2025)
7.11.4 Pacific Biolabs Antimicrobial Efficacy Testing Product Offerings
7.11.5 Pacific Biolabs Recent Development
7.12 MSL Solution Providers
7.12.1 MSL Solution Providers Company Information
7.12.2 MSL Solution Providers Introduction and Business Overview
7.12.3 MSL Solution Providers Antimicrobial Efficacy Testing Sales, Revenue, Price and Gross Margin (2020-2025)
7.12.4 MSL Solution Providers Antimicrobial Efficacy Testing Product Offerings
7.12.5 MSL Solution Providers Recent Development
7.13 Accugen Laboratories
7.13.1 Accugen Laboratories Company Information
7.13.2 Accugen Laboratories Introduction and Business Overview
7.13.3 Accugen Laboratories Antimicrobial Efficacy Testing Sales, Revenue, Price and Gross Margin (2020-2025)
7.13.4 Accugen Laboratories Antimicrobial Efficacy Testing Product Offerings
7.13.5 Accugen Laboratories Recent Development
7.14 Consumer Product Testing Company
7.14.1 Consumer Product Testing Company Company Information
7.14.2 Consumer Product Testing Company Introduction and Business Overview
7.14.3 Consumer Product Testing Company Antimicrobial Efficacy Testing Sales, Revenue, Price and Gross Margin (2020-2025)
7.14.4 Consumer Product Testing Company Antimicrobial Efficacy Testing Product Offerings
7.14.5 Consumer Product Testing Company Recent Development
7.15 Lucideon
7.15.1 Lucideon Company Information
7.15.2 Lucideon Introduction and Business Overview
7.15.3 Lucideon Antimicrobial Efficacy Testing Sales, Revenue, Price and Gross Margin (2020-2025)
7.15.4 Lucideon Antimicrobial Efficacy Testing Product Offerings
7.15.5 Lucideon Recent Development
7.16 BioScience Laboratories
7.16.1 BioScience Laboratories Company Information
7.16.2 BioScience Laboratories Introduction and Business Overview
7.16.3 BioScience Laboratories Antimicrobial Efficacy Testing Sales, Revenue, Price and Gross Margin (2020-2025)
7.16.4 BioScience Laboratories Antimicrobial Efficacy Testing Product Offerings
7.16.5 BioScience Laboratories Recent Development
7.17 ALS Limited
7.17.1 ALS Limited Company Information
7.17.2 ALS Limited Introduction and Business Overview
7.17.3 ALS Limited Antimicrobial Efficacy Testing Sales, Revenue, Price and Gross Margin (2020-2025)
7.17.4 ALS Limited Antimicrobial Efficacy Testing Product Offerings
7.17.5 ALS Limited Recent Development
7.18 Microchem Laboratory
7.18.1 Microchem Laboratory Company Information
7.18.2 Microchem Laboratory Introduction and Business Overview
7.18.3 Microchem Laboratory Antimicrobial Efficacy Testing Sales, Revenue, Price and Gross Margin (2020-2025)
7.18.4 Microchem Laboratory Antimicrobial Efficacy Testing Product Offerings
7.18.5 Microchem Laboratory Recent Development
7.19 Oxford Biosciences Ltd.
7.19.1 Oxford Biosciences Ltd. Company Information
7.19.2 Oxford Biosciences Ltd. Introduction and Business Overview
7.19.3 Oxford Biosciences Ltd. Antimicrobial Efficacy Testing Sales, Revenue, Price and Gross Margin (2020-2025)
7.19.4 Oxford Biosciences Ltd. Antimicrobial Efficacy Testing Product Offerings
7.19.5 Oxford Biosciences Ltd. Recent Development
7.20 Abbott Analytical
7.20.1 Abbott Analytical Company Information
7.20.2 Abbott Analytical Introduction and Business Overview
7.20.3 Abbott Analytical Antimicrobial Efficacy Testing Sales, Revenue, Price and Gross Margin (2020-2025)
7.20.4 Abbott Analytical Antimicrobial Efficacy Testing Product Offerings
7.20.5 Abbott Analytical Recent Development
7.21 Helvic Laboratories
7.21.1 Helvic Laboratories Company Information
7.21.2 Helvic Laboratories Introduction and Business Overview
7.21.3 Helvic Laboratories Antimicrobial Efficacy Testing Sales, Revenue, Price and Gross Margin (2020-2025)
7.21.4 Helvic Laboratories Antimicrobial Efficacy Testing Product Offerings
7.21.5 Helvic Laboratories Recent Development
7.22 Honeyman Group Limited
7.22.1 Honeyman Group Limited Company Information
7.22.2 Honeyman Group Limited Introduction and Business Overview
7.22.3 Honeyman Group Limited Antimicrobial Efficacy Testing Sales, Revenue, Price and Gross Margin (2020-2025)
7.22.4 Honeyman Group Limited Antimicrobial Efficacy Testing Product Offerings
7.22.5 Honeyman Group Limited Recent Development
7.23 Danish Technological Institute
7.23.1 Danish Technological Institute Company Information
7.23.2 Danish Technological Institute Introduction and Business Overview
7.23.3 Danish Technological Institute Antimicrobial Efficacy Testing Sales, Revenue, Price and Gross Margin (2020-2025)
7.23.4 Danish Technological Institute Antimicrobial Efficacy Testing Product Offerings
7.23.5 Danish Technological Institute Recent Development
7.24 BluTest Laboratories Limited
7.24.1 BluTest Laboratories Limited Company Information
7.24.2 BluTest Laboratories Limited Introduction and Business Overview
7.24.3 BluTest Laboratories Limited Antimicrobial Efficacy Testing Sales, Revenue, Price and Gross Margin (2020-2025)
7.24.4 BluTest Laboratories Limited Antimicrobial Efficacy Testing Product Offerings
7.24.5 BluTest Laboratories Limited Recent Development
8 Industry Chain Analysis
8.1 Antimicrobial Efficacy Testing Industrial Chain
8.2 Antimicrobial Efficacy Testing Upstream Analysis
8.2.1 Key Raw Materials
8.2.2 Raw Materials Key Suppliers
8.2.3 Manufacturing Cost Structure
8.3 Midstream Analysis
8.4 Downstream Analysis (Customers Analysis)
8.5 Sales Model and Sales Channels
8.5.1 Antimicrobial Efficacy Testing Sales Model
8.5.2 Sales Channel
8.5.3 Antimicrobial Efficacy Testing Distributors
9 Research Findings and Conclusion
10 Appendix
10.1 Research Methodology
10.1.1 Methodology/Research Approach
10.1.1.1 Research Programs/Design
10.1.1.2 Market Size Estimation
10.1.1.3 Market Breakdown and Data Triangulation
10.1.2 Data Source
10.1.2.1 Secondary Sources
10.1.2.2 Primary Sources
10.2 Author Details
10.3 Disclaimer
TABLE OF FIGURES
List of Tables
List of Figures
KEY QUESTIONS ADDRESSED BY THE REPORT
Related Reports
The global market for Antimicrobial Efficacy Testing was estimated to be worth US$ 338 million in 2025 and is projected to reach US$ 439 million, growing at a CAGR of 3.9% from 2026 to 2032.
Published Date: 2026-06-16
Pages: 159
USD 3950.00
(Single User License)
The global Antimicrobial Efficacy Testing market was valued at US$ 338 million in 2025 and is anticipated to reach US$ 439 million by 2032, at a CAGR of 3.9% from 2026 to 2032.
Published Date: 2026-04-17
Pages: 147
USD 2900.00
(Single User License)
The global Antimicrobial Efficacy Testing market size was US$ 326 million in 2024 and is forecast to a readjusted size of US$ 425 million by 2031 with a CAGR of 3.9% during the forecast period 2025-2031.
Published Date: 2025-11-02
Pages: 114
USD 4250.00
(Single User License)
The global Antimicrobial Efficacy Testing market is projected to grow from US$ 326 million in 2024 to US$ 425 million by 2031, at a CAGR of 3.9% (2025-2031), driven by critical product segments and diverse end‑use applications, while evolving U.S. tariff policies introduce trade‑cost volatility and supply‑chain uncertainty.
Published Date: 2025-11-02
Pages: 198
USD 4900.00
(Single User License)
The global market for Antimicrobial Efficacy Testing was valued at US$ 326 million in the year 2024 and is projected to reach a revised size of US$ 425 million by 2031, growing at a CAGR of 3.9% during the forecast period.
Published Date: 2025-01-13
Pages: 110
USD 2900.00
(Single User License)
Efficacy Testing is a set of procedures in product research and development that are conducted to test the product’s intended purpose in order to substantiate those all-important claims that appear on your packaging or in your advertisements.
Published Date: 2024-01-14
Pages: 109
USD 2900.00
(Single User License)
The global market for Antimicrobial Efficacy Testing was estimated to be worth US$ 338 million in 2025 and is projected to reach US$ 439 million, growing at a CAGR of 3.9% from 2026 to 2032.
Published: 2026-06-16
Pages: 159
The global Antimicrobial Efficacy Testing market was valued at US$ 338 million in 2025 and is anticipated to reach US$ 439 million by 2032, at a CAGR of 3.9% from 2026 to 2032.
Published: 2026-04-17
Pages: 147
The global Antimicrobial Efficacy Testing market size was US$ 326 million in 2024 and is forecast to a readjusted size of US$ 425 million by 2031 with a CAGR of 3.9% during the forecast period 2025-2031.
Published: 2025-11-02
Pages: 114
The global Antimicrobial Efficacy Testing market is projected to grow from US$ 326 million in 2024 to US$ 425 million by 2031, at a CAGR of 3.9% (2025-2031), driven by critical product segments and diverse end‑use applications, while evolving U.S. tariff policies introduce trade‑cost volatility and supply‑chain uncertainty.
Published: 2025-11-02
Pages: 198
The global market for Antimicrobial Efficacy Testing was valued at US$ 326 million in the year 2024 and is projected to reach a revised size of US$ 425 million by 2031, growing at a CAGR of 3.9% during the forecast period.
Published: 2025-01-13
Pages: 110
Efficacy Testing is a set of procedures in product research and development that are conducted to test the product’s intended purpose in order to substantiate those all-important claims that appear on your packaging or in your advertisements.
Published: 2024-01-14
Pages: 109
REPORT COVERAGE
DESCRIPTION
OVERVIEW
MARKET SEGMENTATION
CHAPTER OUTLINE
QYRESEARCH'S STRENGTHS
TABLE OF CONTENTS
TABLE OF FIGURES
RLEATED REPORTS
INTEREST IN THIS REPORT?
Get A Free Sample
Request For Quotation
OR
NEED A CUSTOMIZED REPORT?
Customized Report
Request Sample
Pre-Order Enquiry
Add to Cart
Buy Now